TrialFrontiers in immunology2022

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.

Shengli Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.